Collectively, our data reveal that CCR4 blockade is effective in the overall recovery of various levels of immune dysfunction in HBsAg-specific T cells including both CD4 and CD8 T cells that might help in HBV clearance. This evidence concerns the gene CD4 and immune system disorder.